Related Experiment Video

Updated: Jul 6, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma

Patrick Arbuthnot1, Liam-Jed Thompson

  • 1Antiviral Gene Therapy Research Unit, Department of Molecular Medicine and Haema-tology, University of the Witwatersrand Medical School, Private Bag 3, WITS 2050, South Africa. patrick.arbuthnot@wits.ac.za

World Journal of Gastroenterology
|March 20, 2008
PubMed

Insights

Harnessing RNA interference (RNAi) offers a promising avenue for treating liver cancer, specifically hepatocellular carcinoma (HCC). Overcoming challenges in targeted delivery and minimizing side effects is key to realizing effective RNAi-based therapies for HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Primary liver cancer, particularly hepatocellular carcinoma (HCC), represents a significant global health burden with limited curative treatment options.
  • Hepatocellular carcinoma is the fifth most common malignancy worldwide and a major cause of cancer-related death.
  • Current treatments for HCC are rarely curative, highlighting the urgent need for novel therapeutic strategies.

Purpose of the Study:

  • To explore the potential of RNA interference (RNAi) as a therapeutic strategy for hepatocellular carcinoma (HCC).
  • To review the progress and challenges in developing RNAi-based therapies targeting HCC-related oncogenes and hepatocarcinogenic viruses like HBV and HCV.

Main Methods:

  • Review of existing studies on RNA interference (RNAi) for gene silencing in hepatocellular carcinoma (HCC).
  • Analysis of proof-of-principle studies demonstrating the efficacy of RNAi in preclinical models.
  • Examination of ongoing clinical trials for RNAi-based therapies, including those targeting hepatitis B virus (HBV).

Main Results:

  • Proof-of-principle studies have shown promising results for RNAi-based gene silencing in HCC models.
  • An early clinical trial evaluating RNAi therapy for HBV is currently underway.
  • Significant hurdles remain, including efficient and safe delivery of RNAi effectors to target tissues.

Conclusions:

  • RNA interference (RNAi) holds significant promise for the development of novel hepatocellular carcinoma (HCC) therapies.
  • Efficient and safe delivery of RNAi agents to malignant tissues is a critical challenge.
  • Minimizing unintended off-target effects is essential for the clinical success of RNAi-based HCC treatments.

More Related Videos

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...